DiaMedica Therapeutics
Manufacturing · Minnesota, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
301 Carlson Pkwy Ste 210, Hopkins, Minne...Phone Number
(763) 496-5454Website
www.diamedica.comRevenue
$22.4 MillionStock Symbol
DMACIndustry
About DiaMedica Therapeutics
DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company committed to improving the lives of people suffering from preeclampsia and acute ischemic stroke. DiaMedicas lead candidate, DM199, is the first pharmaceutically active recombinant (synthetic) form of the KLK1 protein, an established therapeutic modality in Asia for the treatment of acute ischemic stroke, preeclampsia and other vascular diseases.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: DMACShow moreDiaMedica Therapeutics Org Chart
Compare Similar Companies to DiaMedica Therapeutics
Compare insights from companies similar to DiaMedica Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
DiaMedica Therapeutics Tech Stack
A closer look at the technologies used by DiaMedica Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding DiaMedica Therapeutics
Sign Up For FreeTo access detailed company insights
DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company committed to improving the lives of people suffering from preeclampsia and acute ischemic stroke. DiaMedicas lead candidate, DM199, is the first pharmaceutically active recombinant (synthetic) form of the KLK1 protein, an established therapeutic modality in Asia for the treat... Read More
